MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide

Unlocking Therapeutic Potential: Theta Burst Stimulation on Multiple Sclerosis—A Systematic Review of Randomized Control Trials